A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis-Reference-Cited by-同舟云学术

A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

Published:2015-09-23 Issue:10 Volume:67 Page:2702-2712
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Sieper J.¹,van der Heijde D.²,Dougados M.³,Maksymowych W. P.⁴,Scott B. B.⁵,Boice J. A.⁵,Berd Y.⁵,Bergman G.⁵,Curtis S.⁵,Tzontcheva A.⁵,Huyck S.⁵,Weng H. H.⁵

Affiliation:

1. University Clinic Benjamin FranklinBerlin Germany

2. Leiden University Medical Centre, Leiden, The Netherlands, University Hospital Maastricht, Maastricht, The Netherlands, and Diakonhjemmet HospitalOslo Norway

3. Paris‐Descartes University, Hôpital Cochin, AP‐HP, INSERM U1153, and PRES Sorbonne Paris‐CitéParis France

4. University of AlbertaEdmonton Alberta Canada

5. Merck & Company, Inc.Kenilworth New Jersey

Funder

Merck & Company, Inc.

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39257

Reference38 articles.